Exact Mass: 399.22569080000005
Exact Mass Matches: 399.22569080000005
Found 500 metabolites which its exact mass value is equals to given mass value 399.22569080000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Spiramine A
Spiramine A is a diterpenoid. It derives from a hydride of an atisane. Spiramine A is a natural product found in Spiraea japonica with data available.
Thiethylperazine
A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p457) R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Thiethylperazine, a phenothiazine derivate, is an orally active and potent dopamine D2-receptor and histamine H1-receptor antagonist. Thiethylperazine is also a selective ABCC1activator that reduces amyloid-β (Aβ) load in mice. Thiethylperazine has anti-emetic, antipsychotic and antimicrobial effects[1][2][3].
Quinacrine
C23H30ClN3O (399.20772800000003)
An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [PubChem] P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
candoxatrilat
C20H33NO7 (399.22569080000005)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
(5Z)-13-Carboxytridec-5-enoylcarnitine
C21H37NO6 (399.26207420000003)
(5Z)-13-Carboxytridec-5-enoylcarnitine is an acylcarnitine. More specifically, it is an (5Z)-tetradec-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z)-13-Carboxytridec-5-enoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5Z)-13-Carboxytridec-5-enoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(7Z)-Tetradec-7-enedioylcarnitine
C21H37NO6 (399.26207420000003)
(7Z)-Tetradec-7-enedioylcarnitine is an acylcarnitine. More specifically, it is an (7Z)-tetradec-7-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (7Z)-Tetradec-7-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (7Z)-Tetradec-7-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2E)-Tetradec-2-enedioylcarnitine
C21H37NO6 (399.26207420000003)
(2E)-Tetradec-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-tetradec-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-Tetradec-2-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (2E)-Tetradec-2-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(4Z)-Tetradec-4-enedioylcarnitine
C21H37NO6 (399.26207420000003)
(4Z)-Tetradec-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an (4Z)-tetradec-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z)-Tetradec-4-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (4Z)-Tetradec-4-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(5E)-Tetradec-5-enedioylcarnitine
C21H37NO6 (399.26207420000003)
(5E)-Tetradec-5-enedioylcarnitine is an acylcarnitine. More specifically, it is an (5E)-tetradec-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5E)-Tetradec-5-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5E)-Tetradec-5-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
21-Desacetyl Deflazacort
C23H29NO5 (399.20456240000004)
Candoxatrilat
C20H33NO7 (399.22569080000005)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Dorsomorphin
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Dorsomorphin (Compound C) is a selective and ATP-competitive AMPK inhibitor (Ki=109 nM in the absence of AMP). Dorsomorphin (BML-275) selectively inhibits BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599)[1][2].
Lenapenem
C18H29N3O5S (399.18278240000006)
Mericitabine
C18H26FN3O6 (399.18055480000004)
Propyl 6-ethyl-5-ethylsulfanylcarbonyl-2-phenyl-4-propylpyridine-3-carboxylate
Phenylalanyl-prolyl-arginine nitrile
Spiradine F
Myriocin-12-en
C21H37NO6 (399.26207420000003)
[Raw Data] CBA30_Myriocin-12-en_neg_40eV_1-4_01_1594.txt [Raw Data] CBA30_Myriocin-12-en_neg_30eV_1-4_01_1593.txt [Raw Data] CBA30_Myriocin-12-en_neg_20eV_1-4_01_1592.txt [Raw Data] CBA30_Myriocin-12-en_neg_10eV_1-4_01_1579.txt [Raw Data] CBA30_Myriocin-12-en_pos_50eV_1-4_01_1564.txt [Raw Data] CBA30_Myriocin-12-en_pos_40eV_1-4_01_1563.txt [Raw Data] CBA30_Myriocin-12-en_pos_30eV_1-4_01_1562.txt [Raw Data] CBA30_Myriocin-12-en_pos_20eV_1-4_01_1561.txt [Raw Data] CBA30_Myriocin-12-en_pos_10eV_1-4_01_1547.txt
(3Z)-3-[[1,6-dimethyl-2-[(1E,3E)-penta-1,3-dienyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(1-hydroxyethyl)pyrrolidine-2,4-dione
(-)-protubonine B|11-epi-protubonine B|protubonine B
6-hydroxy-4-methoxyl-5-[(2E,6E)-(3,7,11-trimethyl-2,6,10-dodecatrien-1-yl)oxy]-2,3-dihydro-1H-isoindol-1-one|emeriphenolicin D
(13R)-2alpha,11alpha-dihydroxy-13-isobutyryloxyhetisane|trichodelphinine B
3-Deoxy-3-methylaminoxylose-beta-D-Furanose-form-Me glycoside, 2,5-dibenzyl, N-Ac|3-Deoxy-3-methylaminoxylose-Me glyoside, n-jAc, 2,5-dibenzyl
C23H29NO5 (399.20456240000004)
2-benzyl-3-phenyl-propionic acid-[2-(2-diethylamino-ethylsulfanyl)-ethyl ester]|2-Benzyl-3-phenyl-propionsaeure-[2-(2-diaethylamino-aethylmercapto)-aethylester]
C24H33NO2S (399.22318780000006)
(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)-3-phenylPropanoic acid
Mepacrine
C23H30ClN3O (399.20772800000003)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent [Raw Data] CB204_Mepacrine_neg_30eV_000037.txt D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors [Raw Data] CB204_Mepacrine_neg_20eV_000037.txt [Raw Data] CB204_Mepacrine_neg_10eV_000037.txt [Raw Data] CB204_Mepacrine_pos_50eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_40eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_30eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_20eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_10eV_isCID-10eV_rep000007.txt
thiethylperazine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Thiethylperazine, a phenothiazine derivate, is an orally active and potent dopamine D2-receptor and histamine H1-receptor antagonist. Thiethylperazine is also a selective ABCC1activator that reduces amyloid-β (Aβ) load in mice. Thiethylperazine has anti-emetic, antipsychotic and antimicrobial effects[1][2][3].
(3Z)-3-[[1,6-dimethyl-2-[(1E,3E)-penta-1,3-dienyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(1-hydroxyethyl)pyrrolidine-2,4-dione
Ala Gly Pro Arg
C16H29N7O5 (399.22300640000003)
Ala Gly Arg Pro
C16H29N7O5 (399.22300640000003)
Ala Asn Pro Val
Ala Asn Val Pro
Ala Pro Gly Arg
C16H29N7O5 (399.22300640000003)
Ala Pro Asn Val
Ala Pro Arg Gly
C16H29N7O5 (399.22300640000003)
Ala Pro Val Asn
Ala Arg Gly Pro
C16H29N7O5 (399.22300640000003)
Ala Arg Pro Gly
C16H29N7O5 (399.22300640000003)
Ala Val Asn Pro
Ala Val Pro Asn
Gly Ala Pro Arg
C16H29N7O5 (399.22300640000003)
Gly Ala Arg Pro
C16H29N7O5 (399.22300640000003)
Gly Ile Asn Pro
Gly Ile Pro Asn
Gly Lys Pro Val
Gly Lys Val Pro
Gly Leu Asn Pro
Gly Leu Pro Asn
Gly Asn Ile Pro
Gly Asn Leu Pro
Gly Asn Pro Ile
Gly Asn Pro Leu
Gly Pro Ala Arg
C16H29N7O5 (399.22300640000003)
Gly Pro Ile Asn
Gly Pro Lys Val
Gly Pro Leu Asn
Gly Pro Asn Ile
Gly Pro Asn Leu
Gly Pro Gln Val
Gly Pro Arg Ala
C16H29N7O5 (399.22300640000003)
Gly Pro Val Lys
Gly Pro Val Gln
Gly Gln Pro Val
Gly Gln Val Pro
Gly Arg Ala Pro
C16H29N7O5 (399.22300640000003)
Gly Arg Pro Ala
C16H29N7O5 (399.22300640000003)
Gly Val Lys Pro
Gly Val Pro Lys
Gly Val Pro Gln
Gly Val Gln Pro
Ile Gly Asn Pro
Ile Gly Pro Asn
Ile Asn Gly Pro
Ile Asn Pro Gly
Ile Pro Gly Asn
Ile Pro Asn Gly
Lys Gly Pro Val
Lys Gly Val Pro
Lys Pro Gly Val
Lys Pro Val Gly
Lys Val Gly Pro
Lys Val Pro Gly
Leu Gly Asn Pro
Leu Gly Pro Asn
Leu Asn Gly Pro
Leu Asn Pro Gly
Leu Pro Gly Asn
Leu Pro Asn Gly
Asn Ala Pro Val
Asn Ala Val Pro
Asn Gly Ile Pro
Asn Gly Leu Pro
Asn Gly Pro Ile
Asn Gly Pro Leu
Asn Ile Gly Pro
Asn Ile Pro Gly
Asn Leu Gly Pro
Asn Leu Pro Gly
Asn Pro Ala Val
Asn Pro Gly Ile
Asn Pro Gly Leu
Asn Pro Ile Gly
Asn Pro Leu Gly
Asn Pro Val Ala
Asn Val Ala Pro
Asn Val Pro Ala
Pro Ala Gly Arg
C16H29N7O5 (399.22300640000003)
Pro Ala Asn Val
Pro Ala Arg Gly
C16H29N7O5 (399.22300640000003)
Pro Ala Val Asn
Pro Gly Ala Arg
C16H29N7O5 (399.22300640000003)
Pro Gly Ile Asn
Pro Gly Lys Val
Pro Gly Leu Asn
Pro Gly Asn Ile
Pro Gly Asn Leu
Pro Gly Gln Val
Pro Gly Arg Ala
C16H29N7O5 (399.22300640000003)
Pro Gly Val Lys
Pro Gly Val Gln
Pro Ile Gly Asn
Pro Ile Asn Gly
Pro Lys Gly Val
Pro Lys Val Gly
Pro Leu Gly Asn
Pro Leu Asn Gly
Pro Asn Ala Val
Pro Asn Gly Ile
Pro Asn Gly Leu
Pro Asn Ile Gly
Pro Asn Leu Gly
Pro Asn Val Ala
Pro Gln Gly Val
Pro Gln Val Gly
Pro Arg Ala Gly
C16H29N7O5 (399.22300640000003)
Pro Arg Gly Ala
C16H29N7O5 (399.22300640000003)
Pro Val Ala Asn
Pro Val Gly Lys
Pro Val Gly Gln
Pro Val Lys Gly
Pro Val Asn Ala
Pro Val Gln Gly
Gln Gly Pro Val
Gln Gly Val Pro
Gln Pro Gly Val
Gln Pro Val Gly
Gln Val Gly Pro
Gln Val Pro Gly
Arg Ala Gly Pro
C16H29N7O5 (399.22300640000003)
Arg Ala Pro Gly
C16H29N7O5 (399.22300640000003)
Arg Gly Ala Pro
C16H29N7O5 (399.22300640000003)
Arg Gly Pro Ala
C16H29N7O5 (399.22300640000003)
Arg Pro Ala Gly
C16H29N7O5 (399.22300640000003)
Arg Pro Gly Ala
C16H29N7O5 (399.22300640000003)
Val Ala Asn Pro
Val Ala Pro Asn
Val Gly Lys Pro
Val Gly Pro Lys
Val Gly Pro Gln
Val Gly Gln Pro
Val Lys Gly Pro
Val Lys Pro Gly
Val Asn Ala Pro
Val Asn Pro Ala
Val Pro Ala Asn
Val Pro Gly Lys
Val Pro Gly Gln
Val Pro Lys Gly
Val Pro Asn Ala
Val Pro Gln Gly
Val Gln Gly Pro
Val Gln Pro Gly
JWH 210 N-(5-carboxypentyl) metabolite
C26H25NO3 (399.18343400000003)
CAR 14:2;O2
C21H37NO6 (399.26207420000003)
1-[3-(9,9-dimethylfluoren-2-yl)phenyl]-3,4-dihydroisoquinoline
1-[(E)-(3-methoxyphenyl)methylideneamino]oxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-ol
C22H29N3O4 (399.21579540000005)
6-(Diethylamino)-1,3-dimethylfluoran
C26H25NO3 (399.18343400000003)
Urea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-phenyl-N-(3-pyridinylmethyl)- (9CI)
butyl 2-methylprop-2-enoate,2-(dimethylamino)ethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate
C21H37NO6 (399.26207420000003)
(S)-3-(3-METHOXYPHENYL)-4-PHENYLOXAZOLIDIN-2-ONE
C23H29NO5 (399.20456240000004)
bis(2-hydroxyethyl)ammonium tetradecyl sulphate
C18H41NO6S (399.2654446000001)
(2S)-2-[[(4R,5R)-1,3-dimethyl-4,5-diphenylimidazolidin-2-ylidene]amino]-3-phenylpropan-1-ol
butyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enamide,2-methylprop-2-enoic acid
C20H33NO7 (399.22569080000005)
carboxymethylcellulose calcium (1.5 g) (as)
C23H30ClN3O (399.20772800000003)
1H-Benzimidazole,5-chloro-2-[1-[(1-cyclohexyl-1H-tetrazol-5-yl)methyl]-4-piperidinyl]-(9CI)
C20H26ClN7 (399.19381060000006)
sodium 2-[methyl(1-oxohexadecyl)amino]ethanesulphonate
C19H38NNaO4S (399.2419108000001)
4-HEXYL-4-[2-(4-ISOTHIOCYANATOPHENYL)ETHYL]-1,1-BIPHENYL
sodium hydrogen (R)-12-(sulphonatooxy)oleate
C18H32NaO6S (399.18171920000003)
(S)-4-(8-amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
1,1,2-Pentanetricarboxylic acid, 4-methyl-, 1,1-bis(phenylmethyl) ester (9CI)
(trans,trans)-4-Pentyl-[1,1-bicyclohexyl]-4-carboxylic acid 4-cyano-3-fluorophenyl ester
5-Methoxy-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
C21H31B2NO5 (399.23882160000005)
Coelenterazine hcp
(S)-1-[(R)-2-METHOXY-1-(4-TRIFLUOROMETHYL-PHENYL)-ETHYL]-2-METHYL-4-(4-METHYL-PIPERIDIN-4-YL)-PIPERAZINE
Desvenlafaxine succinate
C20H33NO7 (399.22569080000005)
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators
Mericitabine
C18H26FN3O6 (399.18055480000004)
C254 - Anti-Infective Agent > C281 - Antiviral Agent
3-[(1S,2S)-2-Hydroxycyclohexyl]-6-[(6-methyl-3-pyridinyl)methyl]benzo[h]quinazolin-4(3H)-one
MK-7622 (M1 receptor modulator) is a muscarinic M1 receptor positive allosteric modulator[1][2].
Urea, N-cyclopropyl-N-(3-((1,2-dihydro-2-oxo-6-quinolinyl)oxy)propyl)-N-((1R,2R)-2-hydroxycyclohexyl)-
C22H29N3O4 (399.21579540000005)
3-fluoro-4-[[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)acetyl]amino]benzoic acid
C23H26FNO4 (399.18457680000006)
1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea
Propyl 6-ethyl-5-ethylsulfanylcarbonyl-2-phenyl-4-propylpyridine-3-carboxylate
D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists MRS 1523 is a potent and selective adenosine A3 receptor antagonist with Ki values of 18.9 nM and 113 nM for human and rat A3 receptors, respectively. In rat this corresponds to selectivities of 140- and 18-fold vs A1 and A2A receptors, respectively. MRS 1523 can exert antihyperalgesic effect through N-type Ca channel block and action potential inhibition in isolated rat dorsal root ganglion (DRG) neurons[1][2].
(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid
5,6-Diphenyl-N-(2-piperazin-1-ylethyl)furo[2,3-D]pyrimidin-4-amine
3-Fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-YL)-acetylamino]-benzoic acid
C23H26FNO4 (399.18457680000006)
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
[4-(3-Aminomethyl-phenyl)-piperidin-1-YL]-(5-phenethyl-pyridin-3-YL)-methanone
N-Cycloheptylglycyl-N-(4-Carbamimidoylbenzyl)-L-Prolinamide
C22H33N5O2 (399.26341180000003)
3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide
N-[2-(1-Formyl-2-methyl-propyl)-1-(4-piperidin-1-YL-but-2-enoyl)-pyrrolidin-3-YL]-methanesulfonamide
C19H33N3O4S (399.2191658000001)
5-Hydroxy-4,4,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)-3-oxocyclohexa-1,5-dien-1-olate
C25H35O4- (399.25352100000003)
(2E,4E,6Z)-8-oxo-8-[(1S,2R,11R)-1,2,5-trimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-11-yl]oxyocta-2,4,6-trienoate
N-(2-amino-3-phenylpropanoyl)-1-[1-cyano-4-(diaminomethylideneamino)butyl]pyrrolidine-2-carboxamide
(4R,5S,6R,7R,9E,11Z)-13-amino-7-hydroxy-4,6-dimethyl-13-oxotrideca-9,11-dien-5-yl (2E)-3-phenylprop-2-enoate
N-(2-furanylmethyl)-2-[4-(phenylmethyl)-1-piperazinyl]-4-quinazolinamine
4-[2-(trifluoromethyl)phenyl]-5-undecyl-4H-1,2,4-triazole-3-thiol
C20H28F3N3S (399.19559240000007)
Aspernidine A
A member of the class of isoindoles that is isoindolin-1-one which is substituted at positions 4, 5 and 6 by hydroxy, triprenyloxy and methoxy groups, respectively. The alkaloid was isolated from the model fungus Aspegillus nidulans.
N-[2-(dipropylamino)ethyl]-5-ethyl-4-oxo-2-thieno[3,2-c]quinolinecarboxamide
C22H29N3O2S (399.19803740000003)
3-[[1-[1-(methylthio)propan-2-yl]-4-piperidinyl]oxy]-N-(2-pyridinylmethyl)benzamide
C22H29N3O2S (399.19803740000003)
1-Butyl-3-[2-(4-ethyl-1-piperazinyl)-4-methyl-6-quinolinyl]-1-methylthiourea
C22H33N5S (399.24565380000007)
2-(3-oxo-2,4-dihydroquinoxalin-1-yl)-2-phenyl-N-(4-propan-2-ylphenyl)acetamide
N-(3-chloro-4-methylphenyl)-2-[3-(5-methyl-2-tetrazolyl)-1-adamantyl]acetamide
C21H26ClN5O (399.18257760000006)
1-[4-(1H-indol-3-ylmethyl)-1-piperazinyl]-2-(2-naphthalenyloxy)ethanone
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
2-(dimethylamino)-N-ethyl-N-[[(2R,3S,4R)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]acetamide
1-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea
2-cyclohexyl-1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one
C23H29NO5 (399.20456240000004)
(1S,10R)-10-Butyl-12-hydroxy-8-(methoxymethyl)-4-phenyl-11-oxa-2,4,6-triaza-12-boratricyclo[7.4.0.02,6]tridec-8-ene-3,5-dione
C20H26BN3O5 (399.19654160000005)
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
(2S,3S,4R)-2-[[[(4-fluorophenyl)-oxomethyl]amino]methyl]-4-(hydroxymethyl)-3-phenyl-N-propyl-1-azetidinecarboxamide
2-(dimethylamino)-N-ethyl-N-[[(2S,3R,4S)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]acetamide
N-[[(2S,3S,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide
N-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide
1-[[(2S,3S,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea
1-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea
(2R,3S)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide
[(2R,3R)-1-(4-oxanylmethyl)-3-phenyl-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
C22H29N3O2S (399.19803740000003)
[(2S,3S)-1-(4-oxanylmethyl)-3-phenyl-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
C22H29N3O2S (399.19803740000003)
(E,4S)-4-[[(2S)-2-[[(2S)-2-(diaminomethylideneazaniumyl)-3-hydroxypropanoyl]amino]-3-methylbutanoyl]-methylamino]-2,5-dimethylhex-2-enoate
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
N-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H29N3O4 (399.21579540000005)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C18H29N3O5S (399.18278240000006)
(2S,3R,4R)-2-[[[(4-fluorophenyl)-oxomethyl]amino]methyl]-4-(hydroxymethyl)-3-phenyl-N-propyl-1-azetidinecarboxamide
N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide
N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide
1-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-3-cyclopentyl-1-methylurea
1-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea
1-[[(2S,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea
1-[(1S,5R)-7-[4-(3-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-2-pyridin-4-ylethanone
(2R,3R)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide
(2S,3R)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide
(2S,3S)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide
[(2S,3R)-2-(hydroxymethyl)-3-phenyl-1-(phenylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-(2-pyridinyl)methanone
[(2S,3R)-1-(4-oxanylmethyl)-3-phenyl-6-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
C22H29N3O2S (399.19803740000003)
(2S,3S,3aR,9bR)-1-(2-cyclopropylacetyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C22H29N3O4 (399.21579540000005)
(2R,3R,3aS,9bS)-1-(2-cyclopropylacetyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C22H29N3O4 (399.21579540000005)
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-[(Z)-1-(2-hydroxyphenyl)ethylideneamino]benzamide
methyl (E)-2-[(3R,4R,6R,7S,8aR)-6-ethyl-4-methyl-2-oxospiro[1H-indole-3,1-3,5,6,7,8,8a-hexahydro-2H-indolizin-4-ium]-7-yl]-3-methoxyprop-2-enoate
(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-3-[(3S)-5-[(1R)-1-hydroxy-3-(methylamino)propyl]pyrrolidin-3-yl]sulfanyl-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
C18H29N3O5S (399.18278240000006)
quinacrine
C23H30ClN3O (399.20772800000003)
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
dorsomorphin
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Dorsomorphin (Compound C) is a selective and ATP-competitive AMPK inhibitor (Ki=109 nM in the absence of AMP). Dorsomorphin (BML-275) selectively inhibits BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599)[1][2].
deacetoxyvindolinium(1+)
The conjugate acid of deacetoxyvindoline arising from protonation of the tertiary amino group; major species at pH 7.3.
colupulone(1-)
A beta-bitter acid(1-) that is the conjugate base of colupulone, obtained by deprotonation of one of the enolic hydroxy groups. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
(5Z)-13-carboxytridec-5-enoylcarnitine
C21H37NO6 (399.26207420000003)
An O-acylcarnitine having (5Z)-13-carboxytridec-5-enoyl as the acyl substituent.
YM-47522
A cinnamate ester obtained by the formal condensation of the carboxy group of trans-cinnamic acid with the 9-hydroxy group of 7,9-dihydroxy-8,10-dimethyltrideca-2,4-dienamide (the 4R,5S,6R,7R,9E,11Z stereoisomer). It is obtained from the fermentation broth of Bacillus sp.YL-03709B and exhibits antifungal activity.
(2z,4e,7s,8s,9r,10s)-7-hydroxy-8,10-dimethyl-9-{[(2e)-3-phenylprop-2-enoyl]oxy}trideca-2,4-dienimidic acid
methyl 18-hydroxy-11-(2-hydroxyethyl)-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate
C23H29NO5 (399.20456240000004)
(1r,2r,5s,7r,8r,13s,18s,21s)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-3-yl acetate
(5s)-3-[(1r,2s,4ar,6r,8ar)-1,6-dimethyl-2-[(1e,3e)-penta-1,3-dien-1-yl]-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1s)-1-hydroxyethyl]-5h-pyrrole-2,4-diol
11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate
(2s,4s,5s,8r,10s,13r,14r,16s,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate
6-methoxy-5-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]-3h-isoindole-1,4-diol
(1r,2r,4s,5r,8s,10r,12s,13s,14r,16r,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate
6-methoxy-5-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}-3h-isoindole-1,4-diol
4,6,6'-trihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-8-one
C23H29NO5 (399.20456240000004)
11-acetyl-1,19-epoxydenudatine
{"Ingredient_id": "HBIN000334","Ingredient_name": "11-acetyl-1,19-epoxydenudatine","Alias": "NA","Ingredient_formula": "C24H33NO4","Ingredient_Smile": "CCN1C2C3CC4C2(C5CCC4(C1O5)C)C6C37CCC(C6OC(=O)C)C(=C)C7O","Ingredient_weight": "399.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "388","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101589674","DrugBank_id": "NA"}
(5r,7r,10s)-isopterocarpolon β-d-gluco-pyranoside
{"Ingredient_id": "HBIN011912","Ingredient_name": "(5r,7r,10s)-isopterocarpolon \u03b2-d-gluco-pyranoside","Alias": "NA","Ingredient_formula": "C21H35O7","Ingredient_Smile": "CC1=CC(=O)CC2(C1CC(CC2)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16073","TCMID_id": "11631","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-[(2r,3r,5s,6r)-6-[(2r)-butan-2-yl]-3,5-dimethyloxan-2-yl]-2,4-dimethoxy-5-phenylpyridin-1-ium-1-olate
methyl (1r,3r,4r,10s,14r,16e,18r)-18-(hydroxymethyl)-14-methyl-15,19-dioxo-12-azapentacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0⁷,²⁰]icosa-7(20),16-diene-3-carboxylate
C23H29NO5 (399.20456240000004)
(1r,2r,4s,5r,8s,10r,12r,13r,14r,15s,16s,18s)-11-ethyl-18-hydroxy-5-methyl-17-methylidene-9-oxa-11-azaheptacyclo[14.2.2.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-15-yl acetate
1,11-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h-cycloundeca[d]isoindole-12,15-dione
{7-[(2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoate
C20H33NO7 (399.22569080000005)
(2s)-4-{[(1s,2r,4as,6r,8ar)-1,6-dimethyl-2-[(1e,3e)-penta-1,3-dien-1-yl]-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl](hydroxy)methylidene}-5-hydroxy-2-(1-hydroxyethyl)-2h-pyrrol-3-one
3,4,5,16,17-pentamethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene
C23H29NO5 (399.20456240000004)
(1r,2r,4s,5r,8s,13s,14r,16s,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate
(1r,2r,4s,5r,8s,10r,12s,13s,14r,16s,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate
4-methoxy-5-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}-3h-isoindole-1,6-diol
4-[5-(1-cyano-1-methylethyl)-2-methyloxolan-2-yl]-3,5-dihydroxy-1,6-dimethyl-octahydronaphthalene-1,6-dicarbonitrile
(4e,11e)-20-hydroxy-11,15,16-trimethyl-18-(2-methylpropyl)-2,7-dioxa-19-azatetracyclo[11.7.0.0¹,¹⁷.0⁶,⁸]icosa-4,11,14,19-tetraen-3-one
methyl 18-(hydroxymethyl)-14-methyl-15,19-dioxo-12-azapentacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0⁷,²⁰]icosa-7(20),16-diene-3-carboxylate
C23H29NO5 (399.20456240000004)
(10r)-3,4,5,16,17-pentamethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene
C23H29NO5 (399.20456240000004)
methyl (1r,3r,4r,10s,14s,16z,18r)-18-(hydroxymethyl)-14-methyl-15,19-dioxo-12-azapentacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0⁷,²⁰]icosa-7(20),16-diene-3-carboxylate
C23H29NO5 (399.20456240000004)
11-ethyl-19-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-16-yl acetate
(1s,2r,5s,7r,8r,12s,13s,18r,20s)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-20-yl acetate
4,6',7-trihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[furo[2,3-f]isoindole-2,1'-naphthalen]-5-one
C23H29NO5 (399.20456240000004)
(1r,2r,5r,7r,8r,9r,10r,13r,16r,17r)-11-ethyl-16-hydroxy-13-methyl-6-methylidene-4-oxo-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-yl acetate
(2s,5s,8r,10s,12s,13r,14r,16r,17r,19r)-11-ethyl-19-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-16-yl acetate
(5s)-3-[(1r,2s,4ar,6r,8ar)-1,6-dimethyl-2-[(1z,3e)-penta-1,3-dien-1-yl]-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1s)-1-hydroxyethyl]-5h-pyrrole-2,4-diol
(10s)-3,4,5,16,17-pentamethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene
C23H29NO5 (399.20456240000004)
3-(2,3-dimethoxy-5-methylphenyl)-5-hydroxy-7-methoxy-2-(3-methylbutyl)-3h-isoindol-1-one
C23H29NO5 (399.20456240000004)
(1r,3s,5s,7r,8r,12r,13r,18s,21r)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-3-yl acetate
(1s,2s,4s,5s,8r,10s,12s,13r,14r,16s,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate
methyl (1r,3r,4r,10s,14s,15s,18r,19s)-18-formyl-15,19-dihydroxy-14-methyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icosa-7(20),16-diene-3-carboxylate
C23H29NO5 (399.20456240000004)
(2z,4e,7r,8r,9s,10r)-7-hydroxy-8,10-dimethyl-9-{[(2e)-3-phenylprop-2-enoyl]oxy}trideca-2,4-dienimidic acid
{7-[(3-hydroxy-3-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxy-2-isopropylbutanoate
C20H33NO7 (399.22569080000005)
(1r,2r,3s,5s,7r,8r,12r,13r,21r)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-3-yl acetate
(3s,3ar,4s,6as,11r,15ar)-1,11-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h-cycloundeca[d]isoindole-12,15-dione
(1r,2r,4s,5r,8s,10r,12r,13s,14r,16r,17r,19r)-11-ethyl-19-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-16-yl acetate
methyl (1r,3r,4r,10s,14r,16z,18r)-18-(hydroxymethyl)-14-methyl-15,19-dioxo-12-azapentacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0⁷,²⁰]icosa-7(20),16-diene-3-carboxylate
C23H29NO5 (399.20456240000004)
(1s,2s,3r,5r,6s,10s)-18-(methoxycarbonyl)-2,6-dimethyl-21-oxo-14-oxa-8-azahexacyclo[11.6.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-13(20),17-dien-8-ium-8-olate
C23H29NO5 (399.20456240000004)
(7r,12r,13r,18s,21r)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-3-yl acetate
(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8as)-7-chloro-3,6-dihydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one
C20H30ClNO5 (399.18124000000006)
(1s,2s,4s,5s,8r,10s,12s,13r,14r,16r,17r,19r)-11-ethyl-19-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-16-yl acetate
(1r,2s,3s,5s,7r,8r,12r,13r,18s,21r)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-3-yl acetate
11-ethyl-16-hydroxy-13-methyl-6-methylidene-4-oxo-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-yl acetate
20-hydroxy-11,15,16-trimethyl-18-(2-methylpropyl)-2,7-dioxa-19-azatetracyclo[11.7.0.0¹,¹⁷.0⁶,⁸]icosa-4,11,14,19-tetraen-3-one
(4z)-5-hydroxy-4-[hydroxy({1,3,6-trimethyl-2-[(1e,3e)-penta-1,3-dien-1-yl]-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl})methylidene]-2-(hydroxymethyl)-2h-pyrrol-3-one
(7r,12r,20s,21r)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-20-yl acetate
(2z,4e)-7-hydroxy-8,10-dimethyl-9-{[(2e)-3-phenylprop-2-enoyl]oxy}trideca-2,4-dienimidic acid
3-[2-(7-chloro-3,6-dihydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one
C20H30ClNO5 (399.18124000000006)
methyl (1r,3r,4r,10s,14r,18r)-18-(hydroxymethyl)-14-methyl-15,19-dioxo-12-azapentacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0⁷,²⁰]icosa-7(20),16-diene-3-carboxylate
C23H29NO5 (399.20456240000004)
(2r,2'r,4'as,6'r,8'as)-4,6,6'-trihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-8-one
C23H29NO5 (399.20456240000004)
[(7r,7ar)-7-{[(2r)-2-methylbutanoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
C20H33NO7 (399.22569080000005)
4-{[1,6-dimethyl-2-(penta-1,3-dien-1-yl)-4a,5,6,7,8,8a-hexahydro-2h-naphthalen-1-yl](hydroxy)methylidene}-5-hydroxy-2-(1-hydroxyethyl)-2h-pyrrol-3-one
(1s,2s,3r,5r,10s)-18-(methoxycarbonyl)-2,6-dimethyl-21-oxo-14-oxa-8-azahexacyclo[11.6.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-13(20),17-dien-8-ium-8-olate
C23H29NO5 (399.20456240000004)
(2r,2'r,4'as,6'r,8'as)-4,6'-dihydroxy-2',5',5',7,8'a-pentamethyl-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-6-one
methyl (1r,2s,6s,15s,16r)-18-hydroxy-11-(2-hydroxyethyl)-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate
C23H29NO5 (399.20456240000004)
(1s,3s,4r,4as,5s,6r,8as)-4-[(2r,5s)-5-(1-cyano-1-methylethyl)-2-methyloxolan-2-yl]-3,5-dihydroxy-1,6-dimethyl-octahydronaphthalene-1,6-dicarbonitrile
(2r,2'r,4'as,6'r,8'ar)-4,6',7-trihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[furo[2,3-f]isoindole-2,1'-naphthalen]-5-one
C23H29NO5 (399.20456240000004)
(1r,4e,6r,8s,11e,13s,16r,17s,18s)-20-hydroxy-11,15,16-trimethyl-18-(2-methylpropyl)-2,7-dioxa-19-azatetracyclo[11.7.0.0¹,¹⁷.0⁶,⁸]icosa-4,11,14,19-tetraen-3-one
methyl (1'r,5's,11'r,12'r)-6-isopropyl-3'-methyl-9'-oxo-2,4-dihydro-3'-azaspiro[pyran-3,15'-tetracyclo[6.5.1.1¹,⁵.0¹¹,¹⁴]pentadecan]-8'(14')-ene-12'-carboxylate
[(7r,7ar)-7-[(2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2,3-dihydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
C20H33NO7 (399.22569080000005)
(1s,2s,3r,5r,6s,8r,10s)-18-(methoxycarbonyl)-2,6-dimethyl-21-oxo-14-oxa-8-azahexacyclo[11.6.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-13(20),17-dien-8-ium-8-olate
C23H29NO5 (399.20456240000004)